Literature DB >> 30898240

Hypertrophic Cardiomyopathy Patients With Paroxysmal Atrial Fibrillation Have a High Burden of Left Atrial Fibrosis by Cardiac Magnetic Resonance Imaging.

Sanjay Sivalokanathan1, Tarek Zghaib2, Gabriela V Greenland3, Nestor Vasquez1, Shibani M Kudchadkar1, Effrosyni Kontari1, Dai-Yin Lu1, Ketty Dolores-Cerna4, Rob J van der Geest5, Ihab R Kamel1, Jeffrey E Olgin6, Theodore P Abraham3, Saman Nazarian7, Stefan L Zimmerman8, M Roselle Abraham9.   

Abstract

OBJECTIVES: This study hypothesized that paroxysmal atrial fibrillation (PAF) reflects the presence of a more severe cardiac hypertrophic cardiomyopathy (HCM) phenotype.
BACKGROUND: HCM is characterized by myocyte hypertrophy, fibrosis, and a high prevalence of PAF. It is currently unresolved whether atrial fibrillation (AF) is a marker or a mediator of adverse outcomes in HCM.
METHODS: This study retrospectively examined 45 HCM patients who underwent cardiovascular magnetic resonance (CMR) imaging in sinus rhythm. The function of all 4 cardiac chambers was assessed, as well as late gadolinium enhancement (LGE) in the left atrium (LA) and left ventricle (LV), as indicators of fibrosis. A fat-saturated, 3-dimensional inversion recovery-prepared, fast-spoiled, gradient-recalled echo sequence, and the image intensity ratio method were used to measure LA-LGE; LGE in the LV was quantified using a semi-automated threshold technique.
RESULTS: HCM patients (n = 45) were divided into 2 groups (PAF, no AF) based on history of PAF. All HCM patients had LGE in the LA posterior wall. The PAF group (n = 18) had higher LA volume, a lower LA ejection fraction, a lower global peak longitudinal LA strain (PLAS), and a higher amount of LA-LGE compared with the no AF group (n = 27). A modest inverse association was noted between the LA ejection fraction, PLAS, and LA-LGE; a positive association was present between LV-LGE and LA-LGE. The PAF group had lower ejection fractions in the LV, right atrium, and right ventricle compared with those in the no AF group.
CONCLUSIONS: PAF is associated with a greater degree of structural LA remodeling and global myopathy, which suggests a more severe cardiac HCM phenotype.
Copyright © 2019 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  cardiovascular magnetic resonance imaging; hypertrophic cardiomyopathy; late gadolinium enhancement in the left atrium; paroxysmal atrial fibrillation

Mesh:

Year:  2018        PMID: 30898240     DOI: 10.1016/j.jacep.2018.10.016

Source DB:  PubMed          Journal:  JACC Clin Electrophysiol        ISSN: 2405-500X


  18 in total

Review 1.  Evaluation of Hypertrophic Cardiomyopathy: Newer Echo and MRI Approaches.

Authors:  Manhal Habib; Sara Hoss; Harry Rakowski
Journal:  Curr Cardiol Rep       Date:  2019-06-26       Impact factor: 2.931

2.  Toward ECG-based analysis of hypertrophic cardiomyopathy: a novel ECG segmentation method for handling abnormalities.

Authors:  Kasra Nezamabadi; Jacob Mayfield; Pengyuan Li; Gabriela V Greenland; Sebastian Rodriguez; Bahadir Simsek; Parvin Mousavi; Hagit Shatkay; M Roselle Abraham
Journal:  J Am Med Inform Assoc       Date:  2022-10-07       Impact factor: 7.942

3.  Clinical Utility of Left Atrial Asynchrony and Mechanical Function in Patients with Hypertrophic Cardiomyopathy.

Authors:  Ozkan Candan; Cetin Gecmen; Muzaffer Kahyaoğlu; Zeki Şimsek; Mehmet Çelik; Abdulkadir Uslu; Cevat Kirma
Journal:  Acta Cardiol Sin       Date:  2022-03       Impact factor: 2.672

4.  Stroke risk in hypertrophic cardiomyopathy patients with atrial fibrillation: a nationwide database study.

Authors:  Jung-Chi Hsu; Ya-Ting Huang; Lian-Yu Lin
Journal:  Aging (Albany NY)       Date:  2020-11-23       Impact factor: 5.682

5.  Predictors of Major Atrial Fibrillation Endpoints in the National Heart, Lung, and Blood Institute HCMR.

Authors:  Christopher M Kramer; John P DiMarco; Paul Kolm; Carolyn Y Ho; Milind Y Desai; Raymond Y Kwong; Sarahfaye F Dolman; Patrice Desvigne-Nickens; Nancy Geller; Dong-Yun Kim; Martin S Maron; Evan Appelbaum; Michael Jerosch-Herold; Matthias G Friedrich; Jeanette Schulz-Menger; Stefan K Piechnik; Masliza Mahmod; Daniel Jacoby; James White; Amedeo Chiribiri; Adam Helms; Lubna Choudhury; Michelle Michels; William Bradlow; Michael Salerno; Dana K Dawson; Jonathan W Weinsaft; Colin Berry; Sherif F Nagueh; Chiara Buccarelli-Ducci; Anjali Owens; Barbara Casadei; Hugh Watkins; William S Weintraub; Stefan Neubauer
Journal:  JACC Clin Electrophysiol       Date:  2021-06-30

6.  Machine Learning Methods for Identifying Atrial Fibrillation Cases and Their Predictors in Patients With Hypertrophic Cardiomyopathy: The HCM-AF-Risk Model.

Authors:  Moumita Bhattacharya; Dai-Yin Lu; Ioannis Ventoulis; Gabriela V Greenland; Hulya Yalcin; Yufan Guan; Joseph E Marine; Jeffrey E Olgin; Stefan L Zimmerman; Theodore P Abraham; M Roselle Abraham; Hagit Shatkay
Journal:  CJC Open       Date:  2021-02-02

7.  Differences in molecular phenotype in mouse and human hypertrophic cardiomyopathy.

Authors:  Styliani Vakrou; Yamin Liu; Li Zhu; Gabriela V Greenland; Bahadir Simsek; Virginia B Hebl; Yufan Guan; Kirubel Woldemichael; Conover C Talbot; Miguel A Aon; Ryuya Fukunaga; M Roselle Abraham
Journal:  Sci Rep       Date:  2021-06-23       Impact factor: 4.996

8.  Characteristics of left atrial remodeling in patients with atrial fibrillation and hypertrophic cardiomyopathy in comparison to patients without hypertrophy.

Authors:  Sotirios Nedios; Borislav Dinov; Timm Seewöster; Frank Lindemann; Sergio Richter; Arash Arya; Nikolaos Dagres; Daniela Husser; Andreas Bollmann; Gerhard Hindricks; Andreas Müssigbrodt
Journal:  Sci Rep       Date:  2021-06-14       Impact factor: 4.379

Review 9.  Deciphering hypertrophic cardiomyopathy with electrocardiography.

Authors:  Thomas Gossios; Konstantinos Savvatis; Thomas Zegkos; Dimitrios Ntelios; Pavlos Rouskas; Despoina Parcharidou; Haralambos Karvounis; Georgios K Efthimiadis
Journal:  Heart Fail Rev       Date:  2021-07-21       Impact factor: 4.654

10.  Implication of Apnea-Hypopnea Index, a Measure of Obstructive Sleep Apnea Severity, for Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy.

Authors:  Haobo Xu; Juan Wang; Jiansong Yuan; Fenghuan Hu; Weixian Yang; Chao Guo; Xiaoliang Luo; Rong Liu; Jingang Cui; Xiaojin Gao; Yushi Chun; Shubin Qiao
Journal:  J Am Heart Assoc       Date:  2020-04-16       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.